VEIEX
Price
$27.63
Change
-$0.39 (-1.39%)
Updated
Sep 6 closing price
VEMRX
Price
$91.73
Change
-$1.31 (-1.41%)
Updated
Sep 6 closing price
Ad is loading...

VEIEX vs VEMRX

Header iconVEIEX vs VEMRX Comparison
Open Charts VEIEX vs VEMRXBanner chart's image
Vanguard Emerging Mkts Stock Idx I
Price$27.63
Change-$0.39 (-1.39%)
VolumeN/A
CapitalizationN/A
Vanguard Emerging Mkts Stock Idx InsPlus
Price$91.73
Change-$1.31 (-1.41%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
VEIEX vs VEMRX Comparison Chart
Loading...
VS
VEIEX vs. VEMRX commentary
Sep 07, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VEIEX is a Buy and VEMRX is a Buy.

FUNDAMENTALS
Fundamentals
VEIEX (108B) and VEMRX (108B) have equal amount of cash in the bank . VEMRX pays higher dividends than VEIEX: VEMRX (3.48) vs VEIEX (3.27). VEIEX was incepted earlier than VEMRX: VEIEX (30 years) vs VEMRX (14 years). VEIEX (5.00) and VEMRX (5.00) have comparable annual turnover. VEIEX has a lower initial minimum investment than VEMRX: VEIEX (0) vs VEMRX (100000000). VEMRX (11.61) and VEIEX (11.44) have marching annual gain over last year. VEMRX (17.73) and VEIEX (16.99) have equivalent 5 years return.
VEIEXVEMRXVEIEX / VEMRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence30 years14 years-
Gain YTD7.8778.01798%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets108B108B100%
Annual Yield % from dividends3.273.4894%
Returns for 1 year11.4411.6199%
Returns for 3 years-10.67-10.30104%
Returns for 5 years16.9917.7396%
Returns for 10 years12.9014.3690%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATS25.550.42
+1.67%
ATS Corp
VRSN183.56-1.33
-0.72%
VeriSign
AMTB20.98-0.24
-1.13%
Amerant Bancorp
TLYS4.75-0.19
-3.85%
Tilly's
MIRA1.58-0.12
-7.06%
MIRA Pharmaceuticals